$ABBV 8K expects to record an impairment charge on intangible assets acquired as part of Stemcentryx acquisition. Estimated impact of this impairment $4Bpic.twitter.comKDR6HEKXSq

$ABBV 8-K expects to record an impairment charge on intangible assets acquired as part of Stemcentryx acquisition. Estimated impact of this impairment ~ $4Bpic.twitter.com/KDR6HEKXSq

17:17 EST 4 Jan 2019 | Odi Bruckman

$ABBV 8-K expects to record an impairment charge on intangible assets acquired as part of Stemcentryx acquisition. Estimated impact of this impairment ~ $4B pic.twitter.com/KDR6HEKXSq

More From BioPortfolio on "$ABBV 8-K expects to record an impairment charge on intangible assets acquired as part of Stemcentryx acquisition. Estimated impact of this impairment ~ $4Bpic.twitter.com/KDR6HEKXSq"